Indianapolis, INDIANA1 Active Studies

Von Willebrand Disease Clinical Trials in Indianapolis, INDIANA

Find 1 actively recruiting von willebrand disease clinical trials in Indianapolis, INDIANA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
31
Enrolling

Recruiting Von Willebrand Disease Studies in Indianapolis

About Von Willebrand Disease Clinical Trials in Indianapolis

Von Willebrand disease is the most common inherited bleeding disorder, caused by deficiency or dysfunction of von Willebrand factor, a protein needed for blood clotting. Most cases are mild with excessive bleeding during surgery or dental work. Treatment includes desmopressin and von Willebrand factor concentrates.

There are currently 1 von willebrand disease clinical trials recruiting participants in Indianapolis, INDIANA. These studies are seeking a combined 31 participants. Research is being sponsored by Baxalta now part of Shire. Clinical trial participation is free and participants receive study-related medical care at no cost.

Von Willebrand Disease Clinical Trials in Indianapolis — FAQ

Are there von willebrand disease clinical trials in Indianapolis?

Yes, there are 1 von willebrand disease clinical trials currently recruiting in Indianapolis, INDIANA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What von willebrand disease treatments are being tested?

The 1 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for von willebrand disease.

Data updated March 2, 2026 from ClinicalTrials.gov